Table 3 Rankings obtained for 29 previously diagnosed cases using our SeqNextGen pipeline compared to Exomiser18 and AMELIE19.

From: A flexible computational pipeline for research analyses of unsolved clinical exome cases

Patient ID

Sequencing platform

SeqNextGen

AMELIE

Exomiser

SNG038

Illumina

1

3

1

SNG081

Illumina

1

1

1

SNG114

Illumina

1

1

1

SNG161

Illumina

4

4

1

SNG024

Illumina

1

13

0

SNG172

Illumina

1

0a

0a

SNG130

Illumina

1

1

1

SNG175

Illumina

1

25

9

SNG173

Illumina

1

2

1

SNG022

Illumina

1

9

1

SNG064

Illumina

1

1

1

SNG035

Illumina

1

3

1

SNG200

Illumina

27

31

45

SNG199

Illumina

13

4

3

SNG095

Illumina

1

4

1

SNG005

Ion Torrent

1

8

2

SNG019

Ion Torrent

1

1

2

SNG021

Ion Torrent

1

1

4

SNG027

Ion Torrent

3

17

15

SNG028

Ion Torrent

1

1

1

SNG062

Ion Torrent

2

0

0

SNG105

Ion Torrent

1

13

3

SNG106

Ion Torrent

1

1

1

SNG066

Ion Torrent

1

2

0

SNG012

Ion Torrent

1

19

10

SNG017

Ion Torrent

4

3

205

SNG018

Ion Torrent

7

5

120

SNG008

Solid

1

1

1

SNG045

Solid

19

14

84

  

Better rank (%)

4 (14%)

2 (7%)

  

Same rank (%)

10 (34%)

12 (41%)

  

Worse rank (%)

15 (52%)

15 (52%)

  

Total

29

29

  1. aAMELIE and Exomiser were unable to give a ranking for this subject as no HPO terms were available. The SeqNextGen pipeline used OMIM terms.